CGT Insurance Coverage
Purpose-built protection for high-cost therapies
Cell and gene therapies, including CAR-T therapies, drive better outcomes but create multimillion-dollar
volatility for self-insured employers. Our stop-loss and reinsurance coverage solutions stabilize costs and enable
access to life-changing care with financial control.
Affordable cell and gene therapy coverage with complementary patient support
The industry's most comprehensive solution:
- All Gene Therapies
- All FDA Approved CAR T-cell Therapies
- Coverage for Ancillary Medical Expenses
- Coverage for Family/Patient’s Travel-related Expenses
1. Standard coverage includes all FDA approved single administration gene therapies that are $850k and greater. Employer groups can select their covered therapies.
Deliver Financial Stability to Your Clients
We recognize the essential role the insurance brokerage community plays as trusted advisors, guiding clients through complex and emerging business risks.
That’s why OutcomeRx partners closely with brokers to educate employers on the rapidly evolving cell and gene therapy (CGT) landscape. Together, we deliver flexible, comprehensive cell and gene therapy insurance coverage solutions designed to address the financial exposure these therapies present — protecting both the organization and its employees.
We collaborate across the full brokerage spectrum, including wholesale specialty brokers, retail brokers and agents, employee benefit brokers and consultants, and reinsurance professionals.